Search

everythinglearnresearchcommunity

for

Search:↓

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

People undergoing chemotherapy need better support and information to cope with hair loss.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Human hair shows promise for non-invasive medical testing, but more research is needed to standardize its use.

Innovative methods are reducing animal testing and improving biomedical research.

Early diagnosis and individualized treatment improve outcomes for Congenital Adrenal Hyperplasia.

Older women face various skin issues like dryness and thinning, and treatments are available but can have side effects; proper skin care and legal health decisions are important.

Mitoxantrone with a corticosteroid helps manage symptoms for some advanced prostate cancer patients but doesn't extend life.

PCOS is complex, affects many, and requires informed management and lifestyle changes.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

The guidelines aim to find treatable prostate cancer early while avoiding unnecessary tests and treatments.

More research is needed on better diagnostics, survivorship, and the impact of genetic mutations in lung cancer.

Drinking a lot of alcohol increases the risk of prostate cancer and can worsen the condition.

Circadian rhythm disruption, chronic inflammation, hormones, metabolism, and genetics may increase prostate cancer risk.

The new drug delivery system effectively targets lung cancer cells.

Certain genetic variants increase the risk of aggressive prostate cancer.

Improving treatment plans can reduce hair loss and improve life quality for ovarian cancer patients.

High levels of ST14 and TMEFF1 proteins in ovarian cancer are linked to worse patient outcomes and may be a new treatment target.

Some cancer and immune system drugs can cause serious side effects, including heart, lung, nerve, and organ damage, which need careful monitoring and management.

New treatments like nanotechnology show promise in improving skin cancer therapy.

% free PSA and urinary markers help better identify prostate cancer.

Diabetes may lower the risk of prostate cancer.

Cell-based screening methods are useful and cost-effective for drug discovery but have pros and cons.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Nanoemulsions can effectively treat skin cancer with fewer side effects.

Ion channels play a key role in ovarian cancer growth and treatment resistance.

Cardamonin may help treat oral cancer by promoting cell death and stopping cancer cell growth.

Ultrasound-based radiomics and radiogenomics can improve ovarian cancer diagnosis and treatment, but need better standardization and AI tools.

Plant-based compounds may offer safer prostate cancer treatment with fewer side effects.

3D bioprinted lung cancer models in a mouse-like structure offer a better way to study radiation effects without using live animals.